NCT01815359 2026-02-05
ICARuS
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT05902533 2025-12-18
REDEL
University of Cincinnati
Phase 2/3 Active not recruiting
NCT02701088 2025-09-22
CANAL-IMRT-01
Centre Francois Baclesse
Phase 2 Active not recruiting
NCT04046133 2025-08-05
CORINTH
Cardiff University
Phase 1 Active not recruiting
NCT02299999 2025-01-15
SAFIR02_Breast
UNICANCER
Phase 2 Active not recruiting
NCT02710734 2024-12-24
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Fox Chase Cancer Center
Phase 2 Active not recruiting
NCT03018418 2024-09-19
Proton Therapy in Reducing Toxicity in Anal Cancer
University of Cincinnati
Phase 2 Active not recruiting
NCT06462001 2024-06-17
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
Nottingham University Hospitals NHS Trust
Phase 3 Active not recruiting